Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr.
SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced that it has launched the roadshow for its proposed initial public offering of 3,850,000 ordinary shares with expected pricing between $11.00 and $13.00 per ordinary share. Antalpha expects to grant the underwriters a
SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer intelligence, today unveiled its latest innovations, led by the premiere of Mira, a game-changing AI teammate marking the next evolution in Meltwater’s AI-powered product suite. Combining the power of AI agents with GenAI,
DUBAI, United Arab Emirates, May 05, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has wrapped up an impactful and illuminating week at TOKEN2049. As a Gold Sponsor, Bitget marked its presence through headline participation, strategic dialogue, and community-focused activations, engaging with key industry leaders, partners,
Felix Bravo Named Managing Director, International at eXp Realty Driving the Next Chapter of Global Agent-Centric Growth BELLINGHAM, Wash., May 02, 2025 (GLOBE NEWSWIRE) — eXp Realty®, the most agent-centric real estate brokerage on the planet™ and core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced the promotion
SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the first quarter of fiscal year 2026 on Wednesday, May 21, 2025, after the market closes. A live Zoom Webinar of the event can be accessed at
